190 related articles for article (PubMed ID: 3274374)
1. A comparison of three immunosuppressive protocols in patients aged over 50 years.
Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
[No Abstract] [Full Text] [Related]
2. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
[No Abstract] [Full Text] [Related]
3. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
4. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
5. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
6. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.
Stuart FP; Stuart JK; Thistlethwaite JR; Gaber AO; Mayes J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1959-60. PubMed ID: 3152656
[No Abstract] [Full Text] [Related]
7. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
8. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
9. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
Gaber AO; Thistlethwaite JR; Haag BW; Stuart J; Mayes J; Fellner S; Stuart FP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
[No Abstract] [Full Text] [Related]
10. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239
[No Abstract] [Full Text] [Related]
11. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Schweizer RT; Rovelli M; Roper L; Bartus SA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
[No Abstract] [Full Text] [Related]
12. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
13. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
14. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
15. Renal transplantation with cyclosporine in the elderly population.
Velez RL; Brinker KR; Vergne-Marini PJ; Nesser DA; Long DL; Trevino G; Dickerman RM; Helfrich GB
Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
[No Abstract] [Full Text] [Related]
16. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
Mieny CJ; Nel PJ; Becker JH; Pretorius JP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1852. PubMed ID: 3079049
[No Abstract] [Full Text] [Related]
17. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
18. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
[No Abstract] [Full Text] [Related]
19. Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation.
Touraine JL; Lefrançois N; Dubernard JM; Garnier JL; Eygonnet JP; Gibelin N; Bétuel H; Traeger J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1881. PubMed ID: 3079055
[No Abstract] [Full Text] [Related]
20. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
Light JA; Aquino A; Ali A; Rodriguez R; Ali S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
